Delivery of transforming growth factor-β2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture

Amr Moursi, Phillip L. Winnard, Doug Fryer, Mark P. Mooney

Research output: Contribution to journalArticle

Abstract

Objective: To determine whether antibody perturbation of Tgf-β, delivered in a collagen gel, could inhibit cranial suture fusion. Design: Attachment and proliferation of osteoblasts cultured on a collagen gel with or without anti-Tgf-β2 antibody were determined by AlamarBlue dye assay and cell morphology by toluidine-blue staining. In rat calvarial organ culture, collagen gel with and without anti-Tgf-β2 antibody was injected subperiosteally over the posterior frontal suture of postnatal day 15 rat calvariae. A quantitative analysis of suture fusion was used to measure suture bridging in histological serial sections at various time points. Results: Attachment and proliferation for cells cultured on collagen gel with anti-Tgf-β2 antibody were similar to collagen gel controls. Although proliferation was lower than on tissue culture plastic, cells treated with anti-Tgf-β2 antibody maintained an osteoblastic morphology. After 7, 10, and 15 days in organ culture, anti-Tgf-β2 antibody treatment caused a reduction in the percent bridging of posterior frontal sutures, compared with controls. Sutures exposed to anti-Tgf-β2 antibody and fibroblast growth factor-2 concurrently did not show an inhibition of bony bridging. Conclusions: These results support previous reports suggesting a role for Tgf-β2 in cranial suture fusion. In cell culture the collagen gel, both with and without anti-Tgf-β2 antibody, promoted similar osteoblast attachment, proliferation, and osteoblastic morphology. In organ culture anti-Tgf-β2 antibody was delivered in a bioactive state via a collagen gel to inhibit cranial suture fusion. Also, the results suggest that the inductive effect of fibroblast growth factor-2 is not dependent on Tgf-β2 activity. Together, these results provide further support for the role of Tgf-β2 in cranial suture fusion.

Original languageEnglish (US)
Pages (from-to)225-232
Number of pages8
JournalCleft Palate-Craniofacial Journal
Volume40
Issue number3
DOIs
StatePublished - May 2003

Fingerprint

Cranial Sutures
Organ Culture Techniques
Transforming Growth Factors
Collagen
Gels
Antibodies
Sutures
Fibroblast Growth Factor 2
Osteoblasts
Cell Culture Techniques
Tolonium Chloride
Skull
Plastics
Cultured Cells
Coloring Agents
Cell Proliferation
Staining and Labeling

Keywords

  • Collagen gel
  • Cranial suture
  • Fibroblast growth factor-2
  • Osteoblast
  • Tgf-β2

ASJC Scopus subject areas

  • Surgery
  • Dentistry(all)

Cite this

Delivery of transforming growth factor-β2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture. / Moursi, Amr; Winnard, Phillip L.; Fryer, Doug; Mooney, Mark P.

In: Cleft Palate-Craniofacial Journal, Vol. 40, No. 3, 05.2003, p. 225-232.

Research output: Contribution to journalArticle

@article{d9e5792cd721451e82544c3af0794dc1,
title = "Delivery of transforming growth factor-β2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture",
abstract = "Objective: To determine whether antibody perturbation of Tgf-β, delivered in a collagen gel, could inhibit cranial suture fusion. Design: Attachment and proliferation of osteoblasts cultured on a collagen gel with or without anti-Tgf-β2 antibody were determined by AlamarBlue dye assay and cell morphology by toluidine-blue staining. In rat calvarial organ culture, collagen gel with and without anti-Tgf-β2 antibody was injected subperiosteally over the posterior frontal suture of postnatal day 15 rat calvariae. A quantitative analysis of suture fusion was used to measure suture bridging in histological serial sections at various time points. Results: Attachment and proliferation for cells cultured on collagen gel with anti-Tgf-β2 antibody were similar to collagen gel controls. Although proliferation was lower than on tissue culture plastic, cells treated with anti-Tgf-β2 antibody maintained an osteoblastic morphology. After 7, 10, and 15 days in organ culture, anti-Tgf-β2 antibody treatment caused a reduction in the percent bridging of posterior frontal sutures, compared with controls. Sutures exposed to anti-Tgf-β2 antibody and fibroblast growth factor-2 concurrently did not show an inhibition of bony bridging. Conclusions: These results support previous reports suggesting a role for Tgf-β2 in cranial suture fusion. In cell culture the collagen gel, both with and without anti-Tgf-β2 antibody, promoted similar osteoblast attachment, proliferation, and osteoblastic morphology. In organ culture anti-Tgf-β2 antibody was delivered in a bioactive state via a collagen gel to inhibit cranial suture fusion. Also, the results suggest that the inductive effect of fibroblast growth factor-2 is not dependent on Tgf-β2 activity. Together, these results provide further support for the role of Tgf-β2 in cranial suture fusion.",
keywords = "Collagen gel, Cranial suture, Fibroblast growth factor-2, Osteoblast, Tgf-β2",
author = "Amr Moursi and Winnard, {Phillip L.} and Doug Fryer and Mooney, {Mark P.}",
year = "2003",
month = "5",
doi = "10.1597/1545-1569(2003)040<0225:DOTGFA>2.0.CO;2",
language = "English (US)",
volume = "40",
pages = "225--232",
journal = "Cleft Palate-Craniofacial Journal",
issn = "1055-6656",
publisher = "American Cleft Palate Craniofacial Association",
number = "3",

}

TY - JOUR

T1 - Delivery of transforming growth factor-β2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture

AU - Moursi, Amr

AU - Winnard, Phillip L.

AU - Fryer, Doug

AU - Mooney, Mark P.

PY - 2003/5

Y1 - 2003/5

N2 - Objective: To determine whether antibody perturbation of Tgf-β, delivered in a collagen gel, could inhibit cranial suture fusion. Design: Attachment and proliferation of osteoblasts cultured on a collagen gel with or without anti-Tgf-β2 antibody were determined by AlamarBlue dye assay and cell morphology by toluidine-blue staining. In rat calvarial organ culture, collagen gel with and without anti-Tgf-β2 antibody was injected subperiosteally over the posterior frontal suture of postnatal day 15 rat calvariae. A quantitative analysis of suture fusion was used to measure suture bridging in histological serial sections at various time points. Results: Attachment and proliferation for cells cultured on collagen gel with anti-Tgf-β2 antibody were similar to collagen gel controls. Although proliferation was lower than on tissue culture plastic, cells treated with anti-Tgf-β2 antibody maintained an osteoblastic morphology. After 7, 10, and 15 days in organ culture, anti-Tgf-β2 antibody treatment caused a reduction in the percent bridging of posterior frontal sutures, compared with controls. Sutures exposed to anti-Tgf-β2 antibody and fibroblast growth factor-2 concurrently did not show an inhibition of bony bridging. Conclusions: These results support previous reports suggesting a role for Tgf-β2 in cranial suture fusion. In cell culture the collagen gel, both with and without anti-Tgf-β2 antibody, promoted similar osteoblast attachment, proliferation, and osteoblastic morphology. In organ culture anti-Tgf-β2 antibody was delivered in a bioactive state via a collagen gel to inhibit cranial suture fusion. Also, the results suggest that the inductive effect of fibroblast growth factor-2 is not dependent on Tgf-β2 activity. Together, these results provide further support for the role of Tgf-β2 in cranial suture fusion.

AB - Objective: To determine whether antibody perturbation of Tgf-β, delivered in a collagen gel, could inhibit cranial suture fusion. Design: Attachment and proliferation of osteoblasts cultured on a collagen gel with or without anti-Tgf-β2 antibody were determined by AlamarBlue dye assay and cell morphology by toluidine-blue staining. In rat calvarial organ culture, collagen gel with and without anti-Tgf-β2 antibody was injected subperiosteally over the posterior frontal suture of postnatal day 15 rat calvariae. A quantitative analysis of suture fusion was used to measure suture bridging in histological serial sections at various time points. Results: Attachment and proliferation for cells cultured on collagen gel with anti-Tgf-β2 antibody were similar to collagen gel controls. Although proliferation was lower than on tissue culture plastic, cells treated with anti-Tgf-β2 antibody maintained an osteoblastic morphology. After 7, 10, and 15 days in organ culture, anti-Tgf-β2 antibody treatment caused a reduction in the percent bridging of posterior frontal sutures, compared with controls. Sutures exposed to anti-Tgf-β2 antibody and fibroblast growth factor-2 concurrently did not show an inhibition of bony bridging. Conclusions: These results support previous reports suggesting a role for Tgf-β2 in cranial suture fusion. In cell culture the collagen gel, both with and without anti-Tgf-β2 antibody, promoted similar osteoblast attachment, proliferation, and osteoblastic morphology. In organ culture anti-Tgf-β2 antibody was delivered in a bioactive state via a collagen gel to inhibit cranial suture fusion. Also, the results suggest that the inductive effect of fibroblast growth factor-2 is not dependent on Tgf-β2 activity. Together, these results provide further support for the role of Tgf-β2 in cranial suture fusion.

KW - Collagen gel

KW - Cranial suture

KW - Fibroblast growth factor-2

KW - Osteoblast

KW - Tgf-β2

UR - http://www.scopus.com/inward/record.url?scp=0038242199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038242199&partnerID=8YFLogxK

U2 - 10.1597/1545-1569(2003)040<0225:DOTGFA>2.0.CO;2

DO - 10.1597/1545-1569(2003)040<0225:DOTGFA>2.0.CO;2

M3 - Article

VL - 40

SP - 225

EP - 232

JO - Cleft Palate-Craniofacial Journal

JF - Cleft Palate-Craniofacial Journal

SN - 1055-6656

IS - 3

ER -